Eton Pharmaceuticals Stock Price Patterns
| ETON Stock | USD 17.10 0.03 0.18% |
Momentum 46
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.13) | EPS Estimate Next Quarter 0.19 | EPS Estimate Current Year 0.37 | EPS Estimate Next Year 1.01 | Wall Street Target Price 30 |
Using Eton Pharmaceuticals hype-based prediction, you can estimate the value of Eton Pharmaceuticals from the perspective of Eton Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Eton Pharmaceuticals using Eton Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Eton using crowd psychology based on the activity and movement of Eton Pharmaceuticals' stock price.
Eton Pharmaceuticals Implied Volatility | 0.98 |
Eton Pharmaceuticals' implied volatility exposes the market's sentiment of Eton Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Eton Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Eton Pharmaceuticals stock will not fluctuate a lot when Eton Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Eton Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Eton because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Eton Pharmaceuticals after-hype prediction price | USD 17.08 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Eton contract
Based on the Rule 16, the options market is currently suggesting that Eton Pharmaceuticals will have an average daily up or down price movement of about 0.0613% per day over the life of the 2026-05-15 option contract. With Eton Pharmaceuticals trading at USD 17.1, that is roughly USD 0.0105 . If you think that the market is fully incorporating Eton Pharmaceuticals' daily price movement you should consider acquiring Eton Pharmaceuticals options at the current volatility level of 0.98%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Eton Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Eton Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Eton Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eton Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Eton Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Eton Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Eton Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eton Pharmaceuticals' historical news coverage. Eton Pharmaceuticals' after-hype downside and upside margins for the prediction period are 14.60 and 19.56, respectively. We have considered Eton Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Eton Pharmaceuticals is not too volatile at this time. Analysis and calculation of next after-hype price of Eton Pharmaceuticals is based on 3 months time horizon.
Eton Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Eton Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eton Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eton Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 2.48 | 0.01 | 0.01 | 6 Events / Month | 7 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
17.10 | 17.08 | 0.06 |
|
Eton Pharmaceuticals Hype Timeline
Eton Pharmaceuticals is currently traded for 17.10. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.01. Eton is estimated to increase in value after the next headline, with the price projected to jump to 17.08 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.06%, whereas the daily expected return is currently at 0.02%. The volatility of related hype on Eton Pharmaceuticals is about 561.09%, with the expected price after the next announcement by competition of 17.11. The company reported the previous year's revenue of 39.01 M. Net Loss for the year was (3.82 M) with profit before overhead, payroll, taxes, and interest of 39.79 M. Given the investment horizon of 90 days the next estimated press release will be in about 6 days. Check out Eton Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Eton Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Eton Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Eton Pharmaceuticals' future price movements. Getting to know how Eton Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eton Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RAPT | RAPT Therapeutics | (0.04) | 8 per month | 2.87 | 0.14 | 7.87 | (6.78) | 64.19 | |
| FULC | Fulcrum Therapeutics | 0.1 | 9 per month | 4.00 | 0.09 | 11.56 | (7.75) | 53.80 | |
| NMRA | Neumora Therapeutics | 0.13 | 7 per month | 3.87 | 0.05 | 10.98 | (7.26) | 33.25 | |
| LXRX | Lexicon Pharmaceuticals | 0.22 | 7 per month | 5.09 | (0.01) | 9.17 | (7.65) | 38.53 | |
| OMER | Omeros | 0.60 | 8 per month | 4.29 | 0.11 | 12.62 | (7.99) | 87.69 | |
| OCGN | Ocugen Inc | 0.02 | 8 per month | 4.53 | 0.02 | 7.25 | (7.43) | 32.50 | |
| MNPR | Monopar Therapeutics | 3.30 | 6 per month | 0.00 | (0.14) | 5.46 | (8.57) | 21.47 | |
| LCTX | Lineage Cell Therapeutics | (0.02) | 6 per month | 0.00 | (0.03) | 6.04 | (5.68) | 19.84 | |
| ADCT | ADC Therapeutics SA | (0.22) | 7 per month | 4.32 | (0.01) | 8.49 | (7.06) | 22.84 | |
| BCYC | Bicycle Therapeutics | 0.33 | 7 per month | 0.00 | (0.10) | 6.06 | (5.88) | 14.20 |
Eton Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Eton price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eton using various technical indicators. When you analyze Eton charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Eton Pharmaceuticals Predictive Indicators
The successful prediction of Eton Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Eton Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Eton Pharmaceuticals based on analysis of Eton Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Eton Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Eton Pharmaceuticals's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.024 | 0.0214 | Price To Sales Ratio | 10.17 | 9.66 |
Pair Trading with Eton Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eton Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Eton Stock
| 0.69 | RHO6 | Roche Holding | PairCorr |
| 0.68 | RO | Roche Holding AG | PairCorr |
| 0.68 | SFZN | Siegfried Holding Earnings Call This Week | PairCorr |
| 0.66 | VTYX | Ventyx Biosciences | PairCorr |
| 0.65 | DYF1 | Dynavax Technologies Earnings Call This Week | PairCorr |
| 0.65 | ELAN | Elanco Animal Health | PairCorr |
The ability to find closely correlated positions to Eton Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eton Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eton Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eton Pharmaceuticals to buy it.
The correlation of Eton Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eton Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eton Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Eton Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Eton Pharmaceuticals Basic Forecasting Models to cross-verify your projections. To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Pharmaceuticals sector continue expanding? Could Eton diversify its offerings? Factors like these will boost the valuation of Eton Pharmaceuticals. Projected growth potential of Eton fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Eton Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.13) | Earnings Share (0.26) | Revenue Per Share | Quarterly Revenue Growth 1.175 | Return On Assets |
Investors evaluate Eton Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Eton Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Eton Pharmaceuticals' market price to deviate significantly from intrinsic value.
It's important to distinguish between Eton Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Eton Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Eton Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.